Pfizer Fair Value Estimate: $47.00 Morningstar Rating: 5 stars Morningstar Economic Moat Rating: Wide Morningstar Uncertainty Rating: Medium We have lowered our fair value estimate for Pfizer stock to $47 per share from $48, based on the disappointing phase 2 obesity study for danuglipron
Monitor fasting glucose and HbA1c before initiating
What Causes Diabetic Ulcer
Obesity and severe obesity prevalence in adults: United States, August 2021August 2023, Centers for Disease Control and Prevention (2024) What to know about the new semaglutide pill for obesity, Journal of the American Medical Association (2026) Medicare coverage of GLP-1 drugs, Library of Congress (2024) BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, U.S
[Another type of test] revealed the presence of semaglutide in all samples, but with considerably lower purity levels [than advertised]
PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways